Danaher Corporation (DAP.DE) XETRA
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In EUR
Address
2200 Pennsylvania Avenue, NW
Washington, DC 20037-1701
United States of America (the)
Phone
202 828 0850
Website
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
61000
First IPO Date
December 15, 2003
| Name | Title | Pay | Year Born |
| Christopher Paul Riley | Executive Vice President of Biotechnology Group & Chief Executive Officer of Cytiva | 2.21M | 1974 |
| Rainer Blair | President, Chief Executive Officer & Director | 5.33M | 1964 |
| Jose-Carlos Gutierrez-Ramos | Senior Vice President & Chief Science Officer | 2.19M | 1962 |
| Julie Sawyer Montgomery | Executive Vice President of Diagnostics Platform | 2.25M | 1973 |
| Matthew E. Gugino | Chief Financial Officer & Executive Vice President | 2.28M | 1983 |
| Matthew R. McGrew | Executive Vice President | 2.77M | 1972 |
| Mitchell Rales | Co-Founder & Director | 0 | 1957 |
| Rachel Marie Vatnsdal Olson | Vice President of Investor Relations | 0 | N/A |
| Martin Stumpe | Chief Technology & AI Officer | 0 | N/A |
| Christopher Bouda | Vice President & Chief Accounting Officer | 0 | N/A |
| Steven Rales | Co-Founder & Chairman | 0 | 1951 |
Danaher Corporation is a global enterprise that develops, produces, and sells a diverse range of specialized products and services tailored for the professional, healthcare, industrial, and commercial sectors. Its operations are organized into three primary divisions: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences division delivers cutting-edge tools and solutions such as mass spectrometers, flow cytometry systems, genomics platforms, laboratory automation, centrifuges, particle analysis equipment, microscopes, and consumables for genomics, alongside Gene and Cell Therapy offerings. It further provides advanced bioprocess technologies, associated consumables, and support services. This segment is also a key supplier of filtration, separation, and purification technologies. Its clientele spans pharmaceutical and biopharmaceutical firms, food and beverage producers, medical organizations, life sciences enterprises, academic institutions including universities and medical schools, research facilities, and diverse industrial manufacturers. The Diagnostics segment specializes in diagnostic solutions, encompassing chemistry, immunoassay, microbiology, and automation systems, in addition to products for hematology, molecular diagnostics, acute care, and pathology. This segment supplies clinical instruments, reagents, consumables, software platforms, and related services to healthcare providers such as hospitals, doctors' offices, reference laboratories, and other vital critical care environments. The Environmental & Applied Solutions division provides a comprehensive suite of instrumentation, consumables, software, services, and disinfection systems. These offerings are crucial for the analysis, treatment, and management of various water types—including ultra-pure, drinking, industrial, waste, groundwater, source water, and ocean water—across residential, commercial, industrial, and natural resource contexts. Furthermore, this segment delivers instruments, software, services, and consumables supporting color and appearance management, packaging design and quality control, packaging conversion, printing, marking, coding, and traceability for consumer, pharmaceutical, and industrial goods. Established in 1969, the company initially operated as Diversified Mortgage Investors, Inc. before adopting the name Danaher Corporation in 1984. Its corporate headquarters are situated in Washington, D.C.